These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19729830)

  • 1. Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue.
    Bhavani V; Srinivasulu M; Ahuja YR; Hasan Q
    Cancer Biomark; 2009; 5(4):207-13. PubMed ID: 19729830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
    Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
    Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker.
    Jing F; Jun L; Yong Z; Wang Y; Fei X; Zhang J; Hu L
    Oncology; 2008; 75(1-2):60-6. PubMed ID: 18784433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population.
    Singh AK; Pandey A; Tewari M; Shukla HS; Pandey HP
    Eur J Cancer Prev; 2011 Nov; 20(6):478-83. PubMed ID: 21572332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
    Butcher DT; Rodenhiser DI
    Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer.
    Jansson A; Carlsson J; Olsson A; Storm P; Margolin S; Gunnarsson C; Stenmark-Askmalm M; Lindblom A; Persson B; Stål O
    Breast Cancer Res Treat; 2007 Nov; 106(1):57-64. PubMed ID: 17260097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
    Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
    Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
    Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
    Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis and characterization of HSD17B2 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.
    Plourde M; Manhes C; Leblanc G; Durocher F; Dumont M; Sinilnikova O; ; Simard J
    J Mol Endocrinol; 2008 Apr; 40(4):161-72. PubMed ID: 18372405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.
    Winter SL; Bosnoyan-Collins L; Pinnaduwage D; Andrulis IL
    BMC Cancer; 2007 May; 7():85. PubMed ID: 17511879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of HSD17B1 and ERBB2 in primary breast cancer.
    Gunnarsson C; Ahnström M; Kirschner K; Olsson B; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
    Oncogene; 2003 Jan; 22(1):34-40. PubMed ID: 12527905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer.
    Gunnarsson C; Jerevall PL; Hammar K; Olsson B; Nordenskjöld B; Jansson A; Stål O
    Breast Cancer Res Treat; 2008 Mar; 108(1):35-41. PubMed ID: 17457667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
    Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
    Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel methylation and expression markers associated with breast cancer].
    Kuznetsova EB; Kekeeva TV; Larin SS; Zemliakova VV; Babenko OV; Nemtsova MV; Zaletaev DV; Strel'nikov VV
    Mol Biol (Mosk); 2007; 41(4):624-33. PubMed ID: 17936981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
    Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
    Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer.
    Charef-Hamza S; Trimeche M; Ziadi S; Amara K; Gaddas N; Mokni M; Sriha B; Yacoubi T; Korbi S
    Cancer Lett; 2005 Jun; 224(2):185-91. PubMed ID: 15914269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different methylation and microRNA expression pattern in male and female familial breast cancer.
    Pinto R; Pilato B; Ottini L; Lambo R; Simone G; Paradiso A; Tommasi S
    J Cell Physiol; 2013 Jun; 228(6):1264-9. PubMed ID: 23160909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array.
    Radpour R; Kohler C; Haghighi MM; Fan AX; Holzgreve W; Zhong XY
    Oncogene; 2009 Aug; 28(33):2969-78. PubMed ID: 19503099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATR-1 hypomethylation is a common and early event in breast cancer.
    Costa FF; Paixão VA; Cavalher FP; Ribeiro KB; Cunha IW; Rinck JA; O'Hare M; Mackay A; Soares FA; Brentani RR; Camargo AA
    Cancer Genet Cytogenet; 2006 Mar; 165(2):135-43. PubMed ID: 16527607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.